Four appointments to the IRCM Board of Directors - Philippe Crine, Pierre Duplessis, Marie-Josée Lamothe and Emmanuel Triassi join the institute's Board

MONTRÉAL, Dec. 15, 2015 /CNW Telbec/ -The IRCM Board of Directors recently confirmed the appointment of four new members: Philippe Crine, President of Crine Consultant; Pierre Duplessis, Management Consultant; Marie-Josée Lamothe, Managing Director of branding and Managing Director for Quebec at Google Canada; and Emmanuel Triassi, Executive Chairman of Groupe TEQ.

"The IRCM's Board of Directors is proud to welcome these four outstanding individuals, who represent important assets for the institute," says Louise Lambert-Lagacé, Chairwoman of the Board. "The IRCM will undoubtedly benefit from their influence and their great knowledge of the business, academic and health sectors."

Philippe Crine is President of Crine Consultant, a firm specializing in business development strategies for North American and European biotechnology companies. With a vast expertise in research and the pharmaceutical industry, he has held several positions including Vice-President of research and Chief Scientific Officer at Enobia Pharma, as well as Founding President of BioMep, a spinoff of his research activities at the Université de Montréal. Dr. Crine holds a Master's and a doctorate degree in biochemistry from the Université de Montréal, and conducted a postdoctoral fellowship at the IRCM under Dr. Michel Chrétien's supervision. From 1978 to 2011, he was professor at the Faculty of Medicine of the Université de Montréal and, from 1989 to 1997, he served as Director of the Department of Biochemistry.

Pierre Duplessis is a management and public health consultant specialized in strategy. He is currently involved in the implementation of international development projects and also as Adjunct Professor at the Université de Montréal School of Public Health. He holds a medical degree from the Université de Montréal, a Master's in public health from Harvard University and a specialty in community medicine from Université Laval. Dr. Duplessis has gained over 30 years of experience in teaching and health care management. For the past several years, he also volunteers with various non-profit organizations and currently chairs the CellCAN Board of Directors. In 2002, he was awarded the Queen Elizabeth II Gold Jubilee Medal.

Marie-Josée Lamothe is Managing Director of branding and Managing Director for Quebec at Google Canada. Having worked in the competitive world of consumer product marketing for 20 years, she is best known for her expertise in international branding. Before joining Google Canada, she held several positions internationally during the 12 years she worked at l'Oréal, including Chief Marketing Officer and Chief Corporate Communications Officer in Canada. In 2012 and 2013, Ms Lamothe was selected by the Financial Post as one of the 100 most influential women in Canada and, in 2015, she was named Person of the year (Personnalité de l'année) by InfoPresse. She is a member of several Boards of Directors, including Reitman's Canada, the Université de Montréal, INCR and the Women's Centre of Montréal Foundation. She is also an Audit Committee Member for the Department of Employment and Social Development, upon recommendation from the Treasury Board of Canada.

Emmanuel Triassi is a seasoned businessman who distinguished himself in the field of construction. He is Executive Chairman of Groupe TEQ, a construction management company he founded in 1984, as well as Vice-Chair of the Board of Directors for Astaldi Canada, for which he was CEO from 2012 to 2015. Mr. Triassi holds a Master's in engineering, project management and construction from Concordia University and a bachelor's degree in civil engineering from McGill University. Member of the Ordre des ingénieurs du Québec, he co-chaired the IRCM Foundation's major fundraising campaign, Give for Life, which surpassed its objective by raising $15.2 million for health research.

About the IRCM
The IRCM (Institut de recherches cliniques de Montréal) is a renowned biomedical research institute located in the heart of Montréal's university district. Founded in 1967, it is currently comprised of 35 research units and four specialized research clinics (cholesterol, cystic fibrosis, diabetes and obesity, hypertension). The IRCM employs nearly 425 people. It is affiliated with the Université de Montréal, and the IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). It also maintains a long-standing association with McGill University. The IRCM is funded by the Quebec ministry of Economy, Innovation and Exports (Ministère de l'Économie, de l'Innovation et des Exportations). For more information, visit www.ircm.qc.ca.

Refer to the IRCM's website for complete biographies and the list of other Board members.

SOURCE Institut de recherches cliniques de Montréal (IRCM)

Julie Langelier, Communications Coordinator (IRCM), [email protected]; Manon Pepin, Executive Director, Communications and public relations (IRCM), [email protected], 514-987-5535